Trial
NCT04711291
Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Veloxis Pharmaceuticals
Condition
Medication Adherence
Intervention
Conversion to Envarsus-XR and use of smart phone app, TransMedAx
Why stopped
PI left organization and study not adopted by any other staff.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-09